APA (7th ed.) Citation

R, W., X, Z., B, R., & W, Z. (2026). SLC26A2 as a key regulator and therapeutic target in hepatocellular carcinoma: Evidence from pan-cancer and mechanistic studies. Human genomics, 20(1), . https://doi.org/10.1186/s40246-026-00970-7

Chicago Style (17th ed.) Citation

R, Wang, Zhang X, Ren B, and Zhou W. "SLC26A2 as a Key Regulator and Therapeutic Target in Hepatocellular Carcinoma: Evidence from Pan-cancer and Mechanistic Studies." Human Genomics 20, no. 1 (2026). https://doi.org/10.1186/s40246-026-00970-7.

MLA (9th ed.) Citation

R, Wang, et al. "SLC26A2 as a Key Regulator and Therapeutic Target in Hepatocellular Carcinoma: Evidence from Pan-cancer and Mechanistic Studies." Human Genomics, vol. 20, no. 1, 2026, https://doi.org/10.1186/s40246-026-00970-7.